EP Patent

EP3914287A1 — Compound decreasing the concentration of 2-hydroxy-glutarate

Assigned to Universitaet Heidelberg · Expires 2021-12-01 · 4y expired

What this patent protects

The present invention relates to a compound decreasing the concentration of 2-hydroxy- glutarate (2HG) in a subject for use in treating, preventing, and/or preventing progression of cardiac remodeling, in particular cardiomyopathy and/or heart failure and to viral particles, comp…

USPTO Abstract

The present invention relates to a compound decreasing the concentration of 2-hydroxy- glutarate (2HG) in a subject for use in treating, preventing, and/or preventing progression of cardiac remodeling, in particular cardiomyopathy and/or heart failure and to viral particles, compositions, uses and methods related thereto.

Drugs covered by this patent

Patent Metadata

Patent number
EP3914287A1
Jurisdiction
EP
Classification
—
Expires
2021-12-01
Drug substance claim
No
Drug product claim
No
Assignee
Universitaet Heidelberg
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.